Clinical Trials Directory

Trials / Completed

CompletedNCT04571515

Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
114 (actual)
Sponsor
Mylan Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

MR-107A-01 is being studied to investigate its efficacy, safety, and dose-response after dental surgery.

Conditions

Interventions

TypeNameDescription
DRUGMR-107A-01Oral tablet
DRUGPlaceboOral tablet

Timeline

Start date
2020-09-29
Primary completion
2020-12-15
Completion
2020-12-22
First posted
2020-10-01
Last updated
2022-08-08
Results posted
2022-08-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04571515. Inclusion in this directory is not an endorsement.

Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain (NCT04571515) · Clinical Trials Directory